foster and thrive hemorrhoidal
- Product NDC
- 70677-1292
- 11-digit product format
- 706771292
- Labeler code
- 70677
- Product ID
- 70677-1292_ad6a2264-a9ec-4b76-b091-02552f867ceb
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- cocoa butter, phenylephrine HCl
- Dosage form
- SUPPOSITORY
- Route
- RECTAL
- Labeler
- Strategic Sourcing Services LLC
- Application
- M015
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2025-06-11
- Substance
- COCOA BUTTER; PHENYLEPHRINE HYDROCHLORIDE
- Active strength
- 2211; 6.5 mg/1; mg/1
- Pharmacologic classes
- Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- foster and thrive hemorrhoidal
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| COCOA BUTTER | 2211 mg/1 |
| PHENYLEPHRINE HYDROCHLORIDE | 6.5 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 512OYT1CRR | Internal UNII lookup |
| 04JA59TNSJ | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 1438497 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| fb3bc359-b06b-4995-aa68-0117a639dff2 | Available on FDA.report |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70677-1292-1 | foster and thrive hemorrhoidal | 12 in 1 CARTON | SUPPOSITORY | 12 | 3 | |
| 70677-1292-1 | foster and thrive hemorrhoidal | 1 in 1 BLISTER PACK | SUPPOSITORY | 1 | 3 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 70677-1292-1 | EA - Each | 70677-1292 | d0dff965-99db-41e8-b367-54d77ffa4f28 | 1 | 2025-07-08 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| HemorrhoidalOintment | MINERAL OIL, PETROLATUM, PHENYLEPHRINE HCI | Trifecta Pharmaceuticals USA LLC | 4eb3c9ac-268a-5246-e054-00144ff88e88 | 2025-06-09 | Warnings | M015 |
| Bunnies Bum Anorectal Numbing | LIDOCAINE | FloCal Distributors LLC | 3712e151-d171-1c5d-e063-6294a90a36c0 | 2025-06-08 | Warnings | M015 |
| RECOVERY Numbing | LIDOCAINE HCL | Renu Laboratories, LLC | e4e05cae-56a6-b2b3-e053-2a95a90a104b | 2025-06-06 | Warnings | M015 |
| Hemorrohoid Master Cream | LIDOCAINE, PHENYLEPHRINE HCL | Ebanel Laboratories, Inc. | 36eccc74-107e-3914-e063-6294a90a1856 | 2025-06-06 | Warnings | M015 |
| Numb 520 | LIDOCAINE | Ebanel Laboratories, Inc | 36c9988b-9e61-ebbf-e063-6394a90a4114 | 2025-06-04 | Warnings | M015 |
| Hemorrhoid Master | LIDOCAINE, PHENYLEPHRINE HCL | Clinical Resolution Laboratory, Inc. | 36caf20d-116a-f86a-e063-6294a90a7b62 | 2025-06-04 | Warnings | M015 |
| Quick Numb | LIDOCAINE | Clinical Resolution Laboratory, Inc. | 351b95a6-e038-d9aa-e063-6294a90a4172 | 2025-05-29 | Warnings | M015 |
| Dibucaine Topical Anesthetic 1% Hemorrhoidal | DIBUCAINE | Rugby Laboratories Inc. | f23c8cd1-98f9-41cd-84d4-cf01c2ede29a | 2025-05-29 | Warnings | M015 |
| The Femme Fix Hemorrhoid Treatment | LIDOCAINE, PHENYLEPHRINE HYDROCHLORIDE | POPPY COLLECTIVE LLC | 5217b5d9-b835-4428-a6b3-e6b255630742 | 2025-05-27 | Warnings | M015 |
| MAXOCAINE Topical Anesthetic Anorectal | LIDOCAINE | PRIME COMMERCE, LLC | 26e8c867-8cb8-4a25-91b1-da45a1edd09a | 2025-05-27 | Warnings | M015 |
| Numb25 | LIDOCAINE | Ebanel Laboratories, Inc. | 35107403-55ae-c627-e063-6394a90a0b5c | 2025-05-27 | Warnings | M015 |
| Numb 520 | LIDOCAINE | Ebanel Laboratories, Inc | 350e4d5e-dac7-ae4e-e063-6394a90a76b4 | 2025-05-27 | Warnings | M015 |
| Numb25 | LIDOCAINE 5% | Ebanel Laboratories, Inc | 350fd302-8fd5-5288-e063-6294a90aa382 | 2025-05-27 | Warnings | M015 |
| Numb 520 | LIDOCAINE | Ebanel Laboratories, Inc | 35095bed-0e91-c44a-e063-6294a90add6e | 2025-05-27 | Warnings | M015 |
| Numb520 | LIDOCAINE | Clinical Resolution Laboratory, Inc. | a0411950-c6ee-4427-acb6-3cef58b0e93e | 2025-05-15 | Warnings | M015 |
| Numb25 | LIDOCAINE | Clinical Resolution Laboratory, Inc. | cfcb839d-47b4-4925-bb30-97b64d20d2b3 | 2025-05-15 | Warnings | M015 |
| Numb520 | LIDOCAINE, PHENYLEPHRINE HYDROCHLORIDE | Clinical Resolution Laboratory, Inc. | 65d3b614-361d-4fb9-9583-a95be754bc82 | 2025-05-15 | Warnings | M015 |
| Chamosyn | BARRIER CREAM | Links Medical Products | f9dfb2d7-4684-4525-994e-1e0ff90413d9 | 2025-05-08 | Warnings | M015 |
| LANOZEM HEMORRHOIDAL | MENTHOL, PETROLATUM | Sod-e Biotech Ltd | 34901e83-8f24-8460-e063-6394a90a2744 | 2025-05-07 | Warnings | M015 |
| PREPARATION H | PHENYLEPHRINE HYDROCHLORIDE | Haleon US Holdings LLC | 96d2e0e7-2de0-4660-9ffd-9edb2ad224d8 | 2025-04-18 | Warnings | M015 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 1438497 | cocoa butter 88.4 % / phenylephrine HCl 0.25 % Rectal Suppository | PSN | fb3bc359-b06b-4995-aa68-0117a639dff2 | 3 |
| 1438497 | cocoa butter 0.884 MG/MG / phenylephrine hydrochloride 0.0025 MG/MG Rectal Suppository | SCD | fb3bc359-b06b-4995-aa68-0117a639dff2 | 3 |
| 1438497 | cocoa butter 88.4 % / phenylephrine HCl 0.25 % Rectal Suppository | SY | fb3bc359-b06b-4995-aa68-0117a639dff2 | 3 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 70677-1292-1 | 70677129201 | 12 BLISTER PACK in 1 CARTON (70677-1292-1) / 1 SUPPOSITORY in 1 BLISTER PACK | 12 blister pack | 2025-06-11 | No | No | Current |